Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67,635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisons.
Xu D, Yu F, Guo T, Zhou Y, Zhang J, Li Y, Jiang S, Mao J, Yang X, Chu L, Chu X, Wang S, Ni J, Zhu Z. Xu D, et al. Among authors: zhou y. Br J Radiol. 2022 Aug 1;95(1136):20220035. doi: 10.1259/bjr.20220035. Epub 2022 Jun 9. Br J Radiol. 2022. PMID: 35611637 Free PMC article.
Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
Guo T, Chu L, Chu X, Yang X, Li Y, Zhou Y, Xu D, Zhang J, Wang S, Hu J, Chu Q, Moran T, Cho WC, Merrell KW, Rizzo S, Liu Y, Ni J, Zhu Z. Guo T, et al. Among authors: zhou y. Transl Lung Cancer Res. 2022 Feb;11(2):173-187. doi: 10.21037/tlcr-22-54. Transl Lung Cancer Res. 2022. PMID: 35280308 Free PMC article.
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer With Brain Metastases.
Yu F, Ni J, Zeng W, Zhou Y, Guo T, Zeng Y, Zhao Y, Li S, Li Y, Yang X, Zou L, Wang S, Liu Q, Li Y, Chu L, Chu X, Ye L, Yu W, Zhu Z. Yu F, et al. Among authors: zhou y. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):804-815. doi: 10.1016/j.ijrobp.2021.05.125. Epub 2021 May 29. Int J Radiat Oncol Biol Phys. 2021. PMID: 34058255
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors.
Zhou Y, Wang B, Qu J, Yu F, Zhao Y, Li S, Zeng Y, Yang X, Chu L, Chu X, Li Y, Zou L, Guo T, Ye L, Liang F, Wang S, Liu Q, Ni J, Zhu Z. Zhou Y, et al. Lung Cancer. 2020 Dec;150:178-185. doi: 10.1016/j.lungcan.2020.10.018. Epub 2020 Nov 5. Lung Cancer. 2020. PMID: 33186860
67,635 results
You have reached the last available page of results. Please see the User Guide for more information.